An open Label, Randomized, Two Way Cross over, Two Period, Two Treatment, two Sequence
Bioequivalence Study of Levomerc tablets (Levofloxacin) 500 mg compared with Tavanic
(Levofloxacin) 500 mg Tablet as reference drug in healthy Pakistani subjects under fasting
condition.
Phase:
Phase 1
Details
Lead Sponsor:
University of Karachi
Collaborators:
Center for bioequivalence studies and clinical reseach (CBSCR), ICCBS, University of Karachi Merck Pvt. Ltd, Pakistan